AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2011
Dec 15, 2011
30793_dirs_2011-12-15_5074495c-35c4-4a22-a167-edd3c2f50bf2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2011-12-13
Reporting Person: MCGONEGAL JEFFREY (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-13 | Common Stock | P | 3625 | $1.58 | Acquired | 48431 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3000 | Indirect |
| Common Stock | 300 | Indirect |
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5